Scientists, It's Time to Speak Up

Ned Shaw Congress and the Bush administration--the same lawmakers who say that they want to spur healthier and longer lives for all Americans and economic growth through the harvest of our medical and health research enterprises--have proposed a historically low FY04 budget increase for the National Institutes of Health. As returns on recent research investments emerge, momentum could be slowed or dismantled by curtailed support for the NIH budget. Those of us who understand the central role t

Written byPaul Rogers
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Congress and the Bush administration--the same lawmakers who say that they want to spur healthier and longer lives for all Americans and economic growth through the harvest of our medical and health research enterprises--have proposed a historically low FY04 budget increase for the National Institutes of Health. As returns on recent research investments emerge, momentum could be slowed or dismantled by curtailed support for the NIH budget. Those of us who understand the central role that research plays in the well-being of our nation have a narrow window in which to act. When scientists speak, lawmakers listen. And scientists must speak now.

While it is true that in deficit times it becomes necessary to tighten the nation's economic belt, nothing could be more destructive than reducing our commitment to medical research funding. It's convenient to believe that all individual scientists need do in respect to public policy is tell their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies